Acumen Pharmaceuticals Cash from Investing (TTM) Analysis

Acumen Pharmaceuticals Inc (ABOS)

3.19 +0.01 (+0.31%) USD | NASDAQ | Apr 25, 16:00

3.185 0.00 (0.00%) Pre-Market: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	-171.67M
September 30, 2023	-143.28M
June 30, 2023	4.636M
March 31, 2023	2.357M
December 31, 2022	39.18M
September 30, 2022	49.59M

Date	Value
June 30, 2022	-100.43M
March 31, 2022	-109.22M
December 31, 2021	-104.12M
September 30, 2021	-94.11M
June 30, 2021	-0.006M
March 31, 2021	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-171.67M

Minimum

Dec 2023

49.59M

Maximum

Sep 2022

-52.26M

Average

-47.06M

Median

Cash from Investing (TTM) Benchmarks